Sinonasal Malignancies of Neuroendocrine OriginRISCHIN, Danny; COLEMAN, Andrew.Hematology/oncology clinics of North America. 2008, Vol 22, Num 6, issn 0889-8588, xi, 1297-1316 [21 p.]Article

Cost-Effectiveness of Universal Hepatitis B Virus Screening in Patients Beginning Chemotherapy for Solid TumorsDAY, Fiona L; KARNON, Jonathan; RISCHIN, Danny et al.Journal of clinical oncology. 2011, Vol 29, Num 24, pp 3270-3277, issn 0732-183X, 8 p.Article

What Is the Best Treatment for Patients With Human Papillomavirus―Positive and ―Negative Oropharyngeal Cancer?URBAN, Damien; CORRY, June; RISCHIN, Danny et al.Cancer. 2014, Vol 120, Num 10, pp 1462-1470, issn 0008-543X, 9 p.Article

Radiation recall reaction following gemcitabineFOGARTY, Gerald; BALL, David; RISCHIN, Danny et al.Lung cancer. 2001, Vol 33, Num 2-3, pp 299-302, issn 0169-5002Article

Larynx Preservation for Patients With Locally Advanced Laryngeal CancerCORRV, June; PETERS, Lester; KLEID, Stephen et al.Journal of clinical oncology. 2013, Vol 31, Num 7, pp 840-844, issn 0732-183X, 5 p.Article

Strategies to overcome accelerated repopulation and hypoxia: What have we learned from clinical trials?CORRY, June; RISCHIN, Danny.Seminars in oncology. 2004, Vol 31, Num 6, pp 802-808, issn 0093-7754, 7 p.Article

Promising results with chemoradiation in patients with sinonasal undifferentiated carcinomaRISCHIN, Danny; PORCEDDU, Sandro; PETERS, Lester et al.Head & neck. 2004, Vol 26, Num 5, pp 435-441, issn 1043-3074, 7 p.Article

Excellent disease control and survival in patients with advanced nasopharyngeal cancer treated with chemoradiationRISCHIN, Danny; CORRY, June; SMITH, Jennifer et al.Journal of clinical oncology. 2002, Vol 20, Num 7, pp 1845-1852, issn 0732-183XArticle

N2-N3 NECK NODAL CONTROL WITHOUT PLANNED NECK DISSECTION FOR CLINICAL/RADIOLOGIC COMPLETE RESPONDERS-RESULTS OF TRANS TASMAN RADIATION ONCOLOGY GROUP STUDY 98.02CORRY, June; PETERS, Lester; FISHER, Richard et al.Head & neck. 2008, Vol 30, Num 6, pp 737-742, issn 1043-3074, 6 p.Article

Resistance to CDK2 Inhibitors Is Associated with Selection of Polyploid Cells in CCNE1-Amplified Ovarian CancerETEMADMOGHADAM, Dariush; AU-YEUNG, George; CARTER, Scott et al.Clinical cancer research (Print). 2013, Vol 19, Num 21, pp 5960-5971, issn 1078-0432, 12 p.Article

Phase II trial of continuous infusion carboplatin, 5-fluorouracil, and radiotherapy for localized cancer of the esophagusJEFFORD, Michael; TONER, Guy C; SMITH, Jennifer G et al.American journal of clinical oncology. 2002, Vol 25, Num 3, pp 277-282, issn 0277-3732Article

A randomised crossover trial of chemotherapy in the home : patient preferences and cost analysisRISCHIN, Danny; WHITE, Michelle A; MATTHEWS, Jane P et al.Medical journal of Australia. 2000, Vol 173, Num 3, pp 125-127, issn 0025-729XArticle

Prognostic Significance of Plasma Osteopontin in Patients with Locoregionally Advanced Head and Neck Squamous Cell Carcinoma Treated on TROG 02.02 Phase III TrialLIM, Annette M; RISCHIN, Danny; LE, Quynh-Thu et al.Clinical cancer research (Print). 2012, Vol 18, Num 1, pp 301-307, issn 1078-0432, 7 p.Article

Relationship between Epidermal Growth Factor Receptor Status, p16^INK4A, and Outcome in Head and Neck Squamous Cell CarcinomaYOUNG, Richard J; RISCHIN, Danny; FISHER, Richard et al.Cancer epidemiology, biomarkers & prevention. 2011, Vol 20, Num 6, pp 1230-1237, issn 1055-9965, 8 p.Article

PROSPECTIVE STUDY OF PERCUTANEOUS ENDOSCOPIC GASTROSTOMY TUBES VERSUS NASOGASTRIC TUBES FOR ENTERAL FEEDING IN PATIENTS WITH HEAD AND NECK CANCER UNDERGOING (CHEMO)RADIATIONCORRY, June; POON, Wendy; MCPHEE, Narelle et al.Head & neck. 2009, Vol 31, Num 7, pp 867-876, issn 1043-3074, 10 p.Article

Long-term survival following chemoradiation for inoperable non-small cell lung cancerPLUMRIDGE, Nikki M; MILLWARD, Michael J; RISCHIN, Danny et al.Medical journal of Australia. 2008, Vol 189, Num 10, pp 557-559, issn 0025-729X, 3 p.Article

An expression-based site of origin diagnostic method designed for clinical application to cancer of unknown originTOTHILL, Richard W; KOWALCZYK, Adam; SUTHERLAND, Robert L et al.Cancer research (Baltimore). 2005, Vol 65, Num 10, pp 4031-4040, issn 0008-5472, 10 p.Article

Paranasal sinus tumors: Peter maccallum cancer institute experiencePORCEDDU, Sandro; MARTIN, Jarad; SHANKER, Gowrie et al.Head & neck. 2004, Vol 26, Num 4, pp 322-330, issn 1043-3074, 9 p.Article

FDG-PET-Detected extracranial metastasis in patients with non-small cell lung cancer undergoing staging for surgery or radical radiotherapy: Survival correlates with metastatic disease burdenMACMANUS, Michael P; HICKS, Rodney; FISHER, Richard et al.Acta oncologica (Stockholm). 2003, Vol 42, Num 1, pp 48-54, issn 0284-186X, 7 p.Article

Improvements in quality of life and disease-related symptoms in Phase I trials of the selective oral epidermal growth factor receptor tyrosine kinase inhibitor ZD1839 in non-small cell Lung Cancer and other solid tumorsLORUSSO, Patricia M; HERBST, Roy S; BJORK, Thomas et al.Clinical cancer research. 2003, Vol 9, Num 6, pp 2040-2048, issn 1078-0432, 9 p.Article

Repetitive high-dose topotecan, carboplatin, and paclitaxel with peripheral blood progenitor cell support in previously untreated ovarian cancer : Results of a phase I studyPRINCE, H. Miles; RISCHIN, Danny; QUINN, Michael et al.Gynecologic oncology (Print). 2001, Vol 81, Num 2, pp 216-224, issn 0090-8258Article

Differential mechanisms of CDKN2A (p16) alteration in oral tongue squamous cell carcinomas and correlation with patient outcomeLIM, Annette M; HONGDO DO; SIGSTON, Elizabeth et al.International journal of cancer (Print). 2014, Vol 135, Num 4, pp 887-895, issn 0020-7136, 9 p.Article

Frequency of Fibroblast Growth Factor Receptor 1 gene amplification in oral tongue squamous cell carcinomas and associations with clinical features and patient outcomeYOUNG, Richard J; LIM, Annette M; RUSSELL, Prudence A et al.Oral oncology (1997). 2013, Vol 49, Num 6, pp 576-581, issn 1368-8375, 6 p.Article

PROSPECTIVE TRIAL TO EVALUATE STAGED NECK DISSECTION OR ELECTIVE NECK RADIOTHERAPY IN PATIENTS WITH CT-STAGED T1-2 NO SQUAMOUS CELL CARCINOMA OF THE ORAL TONGUEBRENNAN, Sinead; CORRY, June; KLEID, Stephen et al.Head & neck. 2010, Vol 32, Num 2, pp 191-198, issn 1043-3074, 8 p.Article

Tirapazamine, Cisplatin, and Radiation Versus Cisplatin and Radiation for Advanced Squamous Cell Carcinoma of the Head and Neck (TROG 02.02, HeadSTART): A Phase III Trial of the Trans-Tasman Radiation Oncology GroupRISCHIN, Danny; PETERS, Lester; HENKE, Michael et al.Journal of clinical oncology. 2010, Vol 28, Num 18, pp 2989-2995, issn 0732-183X, 7 p.Article